We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.24%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.46B
AUM Growth
-$25.5M
Cap. Flow
-$13.6M
Cap. Flow %
-0.93%
Top 10 Hldgs %
23.16%
Holding
4,911
New
1,154
Increased
1,500
Reduced
1,460
Closed
679

Sector Composition

Rank Sector Weight
1 Technology 9.13%
2 Financials 8.46%
3 Industrials 5.89%
4 Healthcare 5.51%
5 Consumer Discretionary 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LCI
1876
DELISTED
Lannett Company, Inc.
LCI
$45K ﹤0.01%
990
+750
+313% +$25.5K
IPHS
1877
DELISTED
Innophos Holdings, Inc.
IPHS
$45K ﹤0.01%
1,384
+1,142
+472% +$32.9K
MDSO
1878
DELISTED
Medidata Solutions, Inc.
MDSO
$45K ﹤0.01%
487
-1,210
-71% -$111K
VSM
1879
DELISTED
Versum Materials, Inc.
VSM
$45K ﹤0.01%
854
-9,092
-91% -$473K
ALE
1880
DELISTED
Allete
ALE
$44K ﹤0.01%
494
-718
-59% -$61.8K
CHE icon
1881
Chemed
CHE
$7.22B
$44K ﹤0.01%
105
-631
-86% -$258K
COKE icon
1882
Coca-Cola Consolidated
COKE
$12.8B
$44K ﹤0.01%
+1,450
New +$45.3K
DRRX
1883
DELISTED
DURECT Corp
DRRX
$44K ﹤0.01%
2,393
-3,690
-61% -$49.9K
ESGR
1884
DELISTED
Enstar Group
ESGR
$44K ﹤0.01%
+230
New +$41.3K
KRG icon
1885
Kite Realty
KRG
$5.36B
$44K ﹤0.01%
2,746
-3,386
-55% -$51.9K
MNOV icon
1886
MediciNova
MNOV
$66M
$44K ﹤0.01%
5,568
-3,469
-38% -$30.9K
MTG icon
1887
MGIC Investment
MTG
$6.25B
$44K ﹤0.01%
3,532
-105,947
-97% -$1.37M
MXL icon
1888
MaxLinear
MXL
$6.8B
$44K ﹤0.01%
1,966
+96
+5% +$2.13K
NPO icon
1889
Enpro
NPO
$7.05B
$44K ﹤0.01%
645
-1,473
-70% -$95.6K
OSIS icon
1890
OSI Systems
OSIS
$3.89B
$44K ﹤0.01%
+434
New +$46.9K
QNST icon
1891
QuinStreet
QNST
$1.21B
$44K ﹤0.01%
3,463
-897
-21% -$12.2K
R icon
1892
Ryder
R
$10.1B
$44K ﹤0.01%
852
-4,984
-85% -$260K
SKM icon
1893
SK Telecom
SKM
$13.2B
$44K ﹤0.01%
+1,189
New +$44.5K
SNDR icon
1894
Schneider National
SNDR
$6.25B
$44K ﹤0.01%
2,033
-53,484
-96% -$1.05M
SPDW icon
1895
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.6B
$44K ﹤0.01%
+1,496
New +$43.4K
USNA icon
1896
Usana Health Sciences
USNA
$286M
$44K ﹤0.01%
648
+310
+92% +$20.8K
WD icon
1897
Walker & Dunlop
WD
$1.53B
$44K ﹤0.01%
779
-972
-56% -$54.5K
VOXX
1898
DELISTED
VOXX International Corporation Class A
VOXX
$44K ﹤0.01%
9,380
-3,917
-29% -$18.1K
FRGI
1899
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$44K ﹤0.01%
4,183
+2,549
+156% +$26.6K
RETA
1900
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$44K ﹤0.01%
545
+513
+1,603% +$43.5K

Similar funds

Tower Research Capital (TRC)'s Q3 2019 Portfolio in Review

As of Q3 2019, Tower Research Capital (TRC) held 4,911 positions worth $1.46B, down 1.7% from $1.48B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC)'s Q3 2019 filing shows 1,154 new, 1,500 increased, 1,460 reduced and 679 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $119M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 4.3% a quarter earlier, followed by Financials and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2019 buy was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M.
  • Tower Research Capital (TRC) added most to State Street Consumer Staples Select Sector SPDR ETF in Q3 2019, an estimated $45.9M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $119M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q3 2019, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $1.46B portfolio in Q3 2019.
  • Tower Research Capital (TRC) opened 1,154 new positions and closed 679 in Q3 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 1.7% quarter-over-quarter to $1.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2019, filed 5 Nov 2019.